Novo to pay up to $2.6 billion to China's Hengrui for rights to weight-loss pill

Technology By Reuters • September 29, 2026, 6:20 PM UTC
⏱ 1 min read 👁 1 views
Direct Source Verification: This story is aggregated from Reuters (reuters.com). Full reporting rights and copyright belong to the primary publisher.
Read on Reuters ↗
Novo to pay up to $2.6 billion to China's Hengrui for rights to weight-loss pill  Reuters
Novo to pay up to $2.6 billion to China's Hengrui for rights to weight-loss pill  Reuters
Original Source
https://news.google.com/rss/articles/CBMivwFBVV95cUxOMWlFaF9yQXl1azczbExDallSSXZxUGd6aTJXVkw5Y3ZiOWRLdTBVcUo1bDl6TEdXNjBPV0hmNEdfaXRhQkJjVHNHTHVDdmhoSUZUT294T3VGbndYN3dNY3I3SXdJNzN6RDlDYUl2M1RZQW9PdENzRUhjWE1tZVk5ZjduZ04xY0VrX1IxS3duN1Faajk1dDFEdDktT2xxZzBPb1cySlZfRlI2SXJCV2dmR2xjc2U0M3IzSU1LbGZmaw?oc=5
Visit Reuters ↗
SHARE STORY:
𝕏 f in

Related Coverage in Technology